Professor Ibrahim A. Alsarra received his Bachelor of Pharmacy (B.S.) in 1996 from College of Pharmacy, King Saud University, Kingdom of Saudi Arabia, and his Doctor of Philosophy (Ph.D.) in Pharmaceutical Biotechnology and Drug Formulation Development, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Missouri, USA. He joined King Saud University in 2002 and was the Assistant Secretary for Research and Scientific Affairs, Arab Pharmacists Union, as well as the Deputy Director for Research and Technical Affairs, Centre of Excellence in Biotechnology Research; the only biotechnology center in Saudi Arabia, King Saud University, till 2021.  He was the President of Saudi Pharmaceutical Society for two terms and the former Editor-in-Chief of Saudi Pharmaceutical Journal for six years, a peer-reviewed and ISI-Indexed Journal with an impact factor of 4.33. Professor Alsarra's research interests include Pharmaceutical Biotechnology, Biosimilars and Biological Products, Drug Delivery, and Controlled Drug Release. Professor Alsarra has more than 15 registered patents: (seven)-US Patents, (Four)-European Patents, and (Four)- Saudi Patents. He has published and edited several books and book chapters and several peer-reviewed papers in highly reputed journals (more than 180 peer-reviewed papers).